Evidence map›Paper›PMID 34717553›Full record

ArticleBMC medical research methodology2021

Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland.

Nicolas Waespe, Sven Strebel, Denis Marino, Veneranda Mattiello, Fanny Muet, Tiago Nava, Christina Schindera, Fabien N Belle, Luzius Mader, Adrian Spoerri and 2 more

2 registry-linked trialsAbstract read
In one paragraph

Article in BMC medical research methodology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03297034 recruitingnot on this map

Swiss Childhood Cancer Survivor Study (SCCSS)

Typeobservational_patient_registrySponsorUniversity of BernRan2007 to 2050Enrolled4,136ConditionsChildhood Cancer
NCT04702321 recruitingnot on this map

Genetic Risks for Childhood Cancer Complications in Switzerland

TypeobservationalSponsorUniversity Hospital, GenevaRan2020 to 2037Enrolled6,000ConditionsChildhood Cancer, Genetic Predisposition, Late EffectArmsProcedure: Biospecimen Collection, Procedure: Medical Chart Review
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Cohort Profile Update: The Swiss Childhood Cancer Survivor Cohort.International journal of epidemiology · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nicolas WaespeChildhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-2271-8959
Sven StrebelChildhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-0576-4865
Denis MarinoCANSEARCH research platform for paediatric oncology and haematology, Faculty of Medicine, Department of Pediatrics, Gynecology, and Obstetrics, University of Geneva, Geneva, Switzerland.
Veneranda MattielloCANSEARCH research platform for paediatric oncology and haematology, Faculty of Medicine, Department of Pediatrics, Gynecology, and Obstetrics, University of Geneva, Geneva, Switzerland.
Fanny MuetCANSEARCH research platform for paediatric oncology and haematology, Faculty of Medicine, Department of Pediatrics, Gynecology, and Obstetrics, University of Geneva, Geneva, Switzerland.
Tiago NavaCANSEARCH research platform for paediatric oncology and haematology, Faculty of Medicine, Department of Pediatrics, Gynecology, and Obstetrics, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-8150-5478
Christina SchinderaChildhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-4511-287X
Fabien N BelleChildhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-0037-4817
Luzius MaderChildhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Adrian SpoerriSwissRDL - Medical Registries and Data Linkage, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0001-5016-9822
Claudia E Kuehni *Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0001-8957-2002
Marc Ansari *CANSEARCH research platform for paediatric oncology and haematology, Faculty of Medicine, Department of Pediatrics, Gynecology, and Obstetrics, University of Geneva, Geneva, Switzerland. marc.ansari@hcuge.ch.ORCID 0000-0002-9649-6498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearch on germline genetic variants relies on enough eligible participants which is difficult to achieve for rare diseases such as childhood cancer. With self-collection kits, participants can contribute genetic samples conveniently from their home. Demographic and clinical factors were identified previously that influenced participation in mailed self-collection. People with pre-existing heritable diagnoses might participate differently in germline DNA collection which might render sampling biased in this group. In this nationwide cross-sectional study, we analysed predictive factors of participation in DNA self-collection including heritable diagnoses.

methodsWe identified childhood cancer survivors from the Swiss Childhood Cancer Registry for invitation to germline DNA self-sampling in September 2019. Participants received saliva sampling kits by postal mail at their home, were asked to fill them, sign an informed consent, and send them back by mail. Two reminders were sent to non-participants by mail. We compared demographic, clinical, and treatment information of participants with non-participants using univariable and multivariable logistic regression models.

resultsWe invited 928 childhood cancer survivors in Switzerland with a median age of 26.5 years (interquartile range 19-37), of which 463 (50%) participated. After the initial send out of the sampling kit, 291 (63%) had participated, while reminder letters led to 172 additional participants (37%). Foreign nationality (odds ratio [OR] 0.5; 95%-confidence interval [CI] 0.4-0.7), survivors aged 30-39 years at study versus other age groups (OR 0.5; CI 0.4-0.8), and survivors with a known cancer predisposition syndrome (OR 0.5; CI 0.3-1.0) were less likely to participate in germline DNA collection. Survivors with a second primary neoplasm (OR 1.9; CI 1.0-3.8) or those living in a French or Italian speaking region (OR 1.3; CI 1.0-1.8) tended to participate more.

conclusionsWe showed that half of childhood cancer survivors participated in germline DNA self-sampling relying completely on mailing of sample kits. Written reminders increased the response by about one third. More targeted recruitment strategies may be advocated for people of foreign nationality, aged 30-39 years, and those with cancer predisposition syndromes. Perceptions of genetic research and potential barriers to participation of survivors need to be better understood.

trial registrationBiobank: https://directory.bbmri-eric.eu/#/collection/bbmri-eric:ID:CH_HopitauxUniversitairesGeneve:collection:CH_BaHOP Research project : Clinicaltrials.gov: NCT04702321 .

Indexed as

Cancer SurvivorsNeoplasmsAdultChildCross-Sectional StudiesDNAHumansSwitzerlandDNACancer survivorsChildhood cancerCohort studyDNADrug side effectsGenetic polymorphismGenetic predispositionGenetic testingRegistrySecond primary neoplasm

Identifiers

PMID34717553
PMCPMC8557596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.